IL6 and coronary artery disorder: We tested this hypothesis and found that while possibly the influence of concomitant medications [75], prevented the CAD case subgroup to yield significant association (p = 0.12), our CAD free control subgroup showed a clear association of ‘C’ allele carriers with elevated circulating IL-6 levels (p = 0.009).